Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

ClinicalTrials.gov ID: NCT00939094

Public ClinicalTrials.gov record NCT00939094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIa, Double-Blind, Randomised, Parallel-Group, Multi-Centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2066 Compared to Placebo in Peripheral Neuropathic Pain Patients With Mechanical Hypersensitivity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate if 28 days of treatment with AZD2066 compared to placebo can relieve the pain arising from the nervous system when the patients are touched by something that should not cause pain or have severe pain when they are touched by something that should only cause a little pain.

Study identification

NCT ID
NCT00939094
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
87 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2009 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Sep 27, 2012

2009 – 2010

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Research Site Tucson Arizona — —
Research Site Los Angeles California — —
Research Site Sacramento California — —
Research Site San Francisco California — —
Research Site Walnut Creek California — —
Research Site Boulder Colorado — —
Research Site Atlantis Florida — —
Research Site Aventura Florida — —
Research Site Clearwater Florida — —
Research Site Fort Myers Florida — —
Research Site Orlando Florida — —
Research Site Palm Beach Gardens Florida — —
Research Site Sarasota Florida — —
Research Site St. Petersburg Florida — —
Research Site Sunrise Florida — —
Research Site Canton Georgia — —
Research Site Marietta Georgia — —
Research Site Evansville Indiana — —
Research Site New Orleans Louisiana — —
Research Site Brockton Massachusetts — —
Research Site Bingham Farms Michigan — —
Research Site Las Vegas Nevada — —
Research Site Reno Nevada — —
Research Site Lumberton New Jersey — —
Research Site Willingboro New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Jacksonville North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Kettering Ohio — —
Research Site Portland Oregon — —
Research Site Bridgeville Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Irving Texas — —
Research Site Lexington Texas — —
Research Site Longview Texas — —
Research Site San Antonio Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00939094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00939094 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →